Endometrial adenocarcinoma associated with drug-induced hyperprolactinemia.
A 54-year-old woman with hyperprolactinemia and amenorrhea that occurred with phenothiazine and tricyclic antidepressant use developed a stage IBG2 endometrial adenocarcinoma. This is believed to be the first case reported of endometrial carcinoma associated with drug-induced hyperprolactinemia.
D000230:Adenocarcinoma / Q000150:complications* / Q000473:pathology; D000328:Adult; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced / Q000150:complications*; D008875:Middle Aged; D009661:Nortriptyline / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013888:Thiothixene / Q000009:adverse effects / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000150:complications* / Q000473:pathology
D013888:Thiothixene; D009661:Nortriptyline